Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2026-05-18 @ 8:53 AM
Study NCT ID:
NCT02638805
Status:
COMPLETED
Last Update Posted:
2018-11-05
First Post:
2015-12-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
Sponsor:
Intarcia Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetes Mellitus, Type 2 | View |
Keywords: